For the Inventor, By the Inventor

Enter assignee name

Rottapharm Spa

USPTO Granted Patents = 26

% Expired Patents = 57.7

CIPO Patents = 2

EPO Patents = 19

Trademarks = 1

Forward Citations = 34

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Lucio C Rovati (20 out of 59 patents)

Francesco Makovec (17 out of 52 patents)

Antonio Giordani (16 out of 30 patents)

4. Gianfranco Caselli (10 out of 28 patents)

5. Stefano Mandelli (6 out of 9 patents)

6. Simona Zanzola (6 out of 9 patents)

7. Ilario Verpilio (4 out of 4 patents)

8. Andrea Zanardi (3 out of 3 patents)

9. Alessandra Cercaci (3 out of 3 patents)

10. Ivan Montaldo (3 out of 3 patents)

11. Roberto Artusi (3 out of 11 patents)

12. Massimo Maria D'Amato (3 out of 4 patents)

13. Francesca Tarchino (3 out of 3 patents)

14. Silvio Mazzari (3 out of 3 patents)

15. Joachim Maus (2 out of 11 patents)

Core Competencies:

Antimicrobial Composition

Dermatological Treatments

Cardiovascular Formulation

Hyaluronic Acid Esters

Neurodegenerative Pathologies

Analgesics

Anti-Inflammatory Agents

COX-2 Inhibitors

Gastrointestinal Disorders

Antipsychotic

Pharmacological Agents

Crystalline Forms

26 patents: Sort by Forward Citations

1. 11998517 - Antimicrobial composition (2024-06-04),

2. 11234997 - Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments (2022-02-01),

3. 10912747 - Antimicrobial composition (2021-02-09),

4. 9623108 - Formulation for oral administration with beneficial effects on the cardiovascular system (2017-04-18),

5. 9174966 - Crystalline forms of 6-(1H-imidazol-1-yl)-2-phenylquinazoline (2015-11-03),

6. 9062129 - Hyaluronic acid esters, their preparation and use in dermatology (2015-06-23),

7. 8809306 - Combination andolast/glucocorticoids (2014-08-19),

8. 8633208 - 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands (2014-01-21),

9. 8420634 - Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies (2013-04-16),

10. 8372866 - 2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain (2013-02-12),

11. 8258185 - Use of neboglamine in the treatment of toxicodependency (2012-09-04),

12. 8193353 - 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents (2012-06-05),

13. 7994181 - 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents (2011-08-09),

14. 7968558 - Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents (2011-06-28),

15. 7906551 - 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors (2011-03-15),

Company Overview

Rottapharm Spa is a prominent pharmaceutical company based in Milan, Italy, specializing in the development and manufacturing of innovative healthcare solutions. The organization focuses on various therapeutic areas, including oncology, cardiology, and infectious diseases, aiming to enhance patient outcomes through advanced medical treatments. With a commitment to research and development, Rottapharm leverages cutting-edge technologies to create effective pharmaceuticals and improve healthcare delivery across diverse markets.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

26 Patents

#71 in Milan

#358 in Italy

#24,806 in the World

Rottapharm Spa

Forward Citations = 34

38 inventors:

Lucio C Rovati (20 out of 59 patents)

Francesco Makovec (17 out of 52 patents)

Antonio Giordani (16 out of 30 patents)

4. Gianfranco Caselli (10 out of 28 patents)

5. Stefano Mandelli (6 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rottapharm Spa. Retrieved from https://idiyas.com/company/rottapharm-spa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…